1995
DOI: 10.1016/s0033-0620(05)80001-5
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide and its role in the cardiovascular system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
286
1
20

Year Published

1999
1999
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 532 publications
(315 citation statements)
references
References 135 publications
4
286
1
20
Order By: Relevance
“…The principle vasodilating agent generated in conduit vessels is currently thought of as being NO (41). We proposed that an increased production of basal NO would lower the contractions to all of the agonists used in this study.…”
Section: Discussionmentioning
confidence: 95%
“…The principle vasodilating agent generated in conduit vessels is currently thought of as being NO (41). We proposed that an increased production of basal NO would lower the contractions to all of the agonists used in this study.…”
Section: Discussionmentioning
confidence: 95%
“…The eNOS, encoded by the NOS3 gene, is the principal source of NO within cardiovascular cells. Vascular NO derived from eNOS modulates numerous essential vascular functions, including regulation of blood pressure, inhibition of platelet aggregation, and inhibition of leukocyte adhesion, among others (see review 20 ). While we focus on eNOS regulation by S1P receptor systems in this article, readers are invited to another review paper in which we discussed more general aspects of the eNOS/NO system.…”
Section: Cellular Sources Of Blood Sphingosine-1-phosphate That Modulmentioning
confidence: 99%
“…Since platelet-related molecules other than S1P, including thrombin, 20 are also able to activate eNOS, it remains to be determined whether or not S1P activates eNOS in the face of vascular coagulation in vivo. Yet in blood vessels in which S1P exerts overall vasoconstriction responses, the local production of S1P by platelets might help reduce bleeding by decreasing local blood flow.…”
Section: Pathophysiological Implications Of Sphingosine-1-phosphate-imentioning
confidence: 99%
“…Nitric oxide (NO), essential for the proper functioning of the cardiovascular system, is derived from L-arginine by NO synthase (NOS) in endothelial cells. NO synthase inhibition produces various cardiovascular abnormalities and ventricular contractile dysfunction (Loscalzo and Welch, 1995;Dickinson and Forman, 2002). Although no previous report has investigated TAS, TOS, and OSI as biomarkers of oxidative stress and antioxidant defence related to treating the rabbits with enrofloxacin, a possible explanation for this might be that free oxidant radicals are not produced.…”
Section: Discussionmentioning
confidence: 99%